The Discovery Bottleneck
Effective discovery programs require diverse, well-characterized datasets that reflect populations from around the world. While Africa is one of the most genetically rich and clinically diverse regions, biotech companies, pharmaceutical firms, and academic researchers often spend months, sometimes years, trying to access high-quality datasets that are standardized and research-ready.
BioVana bridges this gap by working with hospitals and biobanks to structure and prepare datasets for global research, creating trusted pathways for researchers to identify relevant cohorts and access compliant datasets and biospecimens efficiently and ethically.
What You Gain
FAIR-Compliant Data
OMOP-Aligned Datasets
Work with standardized clinical datasets structured in alignment with the OMOP common data model, making it easier to integrate data into your analytics pipelines, multi-site studies, and AI models.
Faster Discovery & Validation
How We Accelerate Trials
For Pharma & Biotech
Identify African sites with ISO 20387-certified biobanks
Access aggregated cohort data without individual-level exposure
Request data briefs on population genetics and disease prevalence
Partner with sites under fair, transparent governance terms
For CROs & Academia
Search BioVana Index for available samples and cohorts
Connect with African researchers for collaborative trials
Access standardized MIABIS/OMOP data for protocol design
Leverage certified sites to meet regulatory requirements
For African Sites
Showcase your capabilities to global research networks
Receive trial opportunities aligned with your expertise
Negotiate partnerships from a position of strength and sovereignty
Generate revenue while advancing African health priorities